Furthermore, SHP-1 has been demonstrated to be involved in the dovitinib-mediated effect on kinase inhibition, phosphorylated (p)-STAT3 and apoptosis in HCC (54). This evidence concerns the gene STAT3 and hepatocellular carcinoma.